
Sun Jae Yoo
Examiner (ID: 4021, Phone: (571)272-9074 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1622, 1609, 1626, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1172 |
| Pending Applications | 219 |
| Abandoned Applications | 564 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16236762
[patent_doc_number] => 20200253996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => TCTP INHIBITING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES, INFECTIOUS DISEASES, ALLERGIES, INFLAMMATIONS AND/OR ASTHMA
[patent_app_type] => utility
[patent_app_number] => 16/651719
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19236
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16651719
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/651719 | TCTP INHIBITING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES, INFECTIOUS DISEASES, ALLERGIES, INFLAMMATIONS AND/OR ASTHMA | Sep 30, 2018 | Abandoned |
Array
(
[id] => 15589537
[patent_doc_number] => 20200071303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => DIPHENYLAMINOPYRIMIDINE COMPOUND FOR INHIBITING KINASE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/492994
[patent_app_country] => US
[patent_app_date] => 2018-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14480
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492994
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492994 | Diphenylaminopyrimidine compound for inhibiting kinase activity | Sep 29, 2018 | Issued |
Array
(
[id] => 14852049
[patent_doc_number] => 10414736
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-17
[patent_title] => Method of preparing ezetimibe and intermediate thereof
[patent_app_type] => utility
[patent_app_number] => 16/146129
[patent_app_country] => US
[patent_app_date] => 2018-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 4142
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16146129
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/146129 | Method of preparing ezetimibe and intermediate thereof | Sep 27, 2018 | Issued |
Array
(
[id] => 14777791
[patent_doc_number] => 20190263793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/140392
[patent_app_country] => US
[patent_app_date] => 2018-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16140392
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/140392 | Benzoxazepin oxazolidinone compounds and methods of use | Sep 23, 2018 | Issued |
Array
(
[id] => 16283666
[patent_doc_number] => 20200277268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => PENTAFLUOROPHENYL SULFONAMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/649806
[patent_app_country] => US
[patent_app_date] => 2018-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22338
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16649806
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/649806 | PENTAFLUOROPHENYL SULFONAMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF | Sep 20, 2018 | Abandoned |
Array
(
[id] => 18545260
[patent_doc_number] => 11718599
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Method for producing cyclic carbonate having unsaturated group, and novel cyclic carbonate
[patent_app_type] => utility
[patent_app_number] => 16/754980
[patent_app_country] => US
[patent_app_date] => 2018-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6018
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 243
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754980
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/754980 | Method for producing cyclic carbonate having unsaturated group, and novel cyclic carbonate | Sep 19, 2018 | Issued |
Array
(
[id] => 16072281
[patent_doc_number] => 20200190127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => NEW CRYSTAL FORM OF A DITHIOLENE METAL COMPLEX
[patent_app_type] => utility
[patent_app_number] => 16/638875
[patent_app_country] => US
[patent_app_date] => 2018-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638875
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638875 | Crystal form of a dithiolene metal complex | Sep 17, 2018 | Issued |
Array
(
[id] => 16267201
[patent_doc_number] => 20200268688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => FLUOROPHENYL BETA-HYDROXYETHYLAMINES AND THEIR USE IN THE TREATMENT OF HYPERGLYCAEMIA
[patent_app_type] => utility
[patent_app_number] => 16/646497
[patent_app_country] => US
[patent_app_date] => 2018-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21615
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646497
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/646497 | Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia | Sep 12, 2018 | Issued |
Array
(
[id] => 13733097
[patent_doc_number] => 20180371016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => TRIFLUOROMETHYLPROPANAMIDE DERIVATIVES AS HTRA1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/121300
[patent_app_country] => US
[patent_app_date] => 2018-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21331
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -51
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16121300
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/121300 | Trifluoromethylpropanamide derivatives as HTRA1 inhibitors | Sep 3, 2018 | Issued |
Array
(
[id] => 16390959
[patent_doc_number] => 20200331900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => COMPOUNDS, COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/643168
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16643168
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/643168 | Compounds, compositions and methods | Aug 30, 2018 | Issued |
Array
(
[id] => 14099159
[patent_doc_number] => 20190091255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => COMPOSITIONS, KITS, AND METHODS TO INDUCE ACQUIRED CYTORESISTANCE USING STRESS PROTEIN INDUCERS
[patent_app_type] => utility
[patent_app_number] => 16/116411
[patent_app_country] => US
[patent_app_date] => 2018-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32546
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16116411
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/116411 | Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers | Aug 28, 2018 | Issued |
Array
(
[id] => 13793249
[patent_doc_number] => 20190010163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
[patent_app_type] => utility
[patent_app_number] => 16/116559
[patent_app_country] => US
[patent_app_date] => 2018-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11930
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16116559
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/116559 | Compounds useful as inhibitors of ATR kinase | Aug 28, 2018 | Issued |
Array
(
[id] => 16452435
[patent_doc_number] => 20200361861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => OLIGOTHIOETHERAMIDES (OLIGOTEAS) AS ANTI-MICROBIAL AND ANTI-BACTERIAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/639896
[patent_app_country] => US
[patent_app_date] => 2018-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16639896
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/639896 | Oligothioetheramides (oligoteas) as anti-microbial and anti-bacterial agents | Aug 16, 2018 | Issued |
Array
(
[id] => 16206504
[patent_doc_number] => 20200239494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/639555
[patent_app_country] => US
[patent_app_date] => 2018-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 128277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 1346
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16639555
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/639555 | MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE | Aug 14, 2018 | Abandoned |
Array
(
[id] => 13955425
[patent_doc_number] => 20190054056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => PRECURSOR COMPOUNDS FOR PROVIDING RETINOIDS OF THE VATAMIN A5 PATHWAY AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/102137
[patent_app_country] => US
[patent_app_date] => 2018-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16102137
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/102137 | Precursor compounds for providing retinoids of the vitamin A5 pathway and uses thereof | Aug 12, 2018 | Issued |
Array
(
[id] => 17713466
[patent_doc_number] => 11377449
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-05
[patent_title] => BTK inhibitors with improved dual selectivity
[patent_app_type] => utility
[patent_app_number] => 16/637615
[patent_app_country] => US
[patent_app_date] => 2018-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 21084
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16637615
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/637615 | BTK inhibitors with improved dual selectivity | Aug 11, 2018 | Issued |
Array
(
[id] => 14566769
[patent_doc_number] => 20190210991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => PROCESS OF PRODUCING CYCLOALKYLCARBOXAMIDO-INDOLE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/059724
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16059724
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/059724 | PROCESS OF PRODUCING CYCLOALKYLCARBOXAMIDO-INDOLE COMPOUNDS | Aug 8, 2018 | Abandoned |
Array
(
[id] => 16090181
[patent_doc_number] => 20200199077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => PROCESS FOR MANUFACTURING A CYCLIC UREA ADDUCT OF AN ETHYLENEAMINE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/638390
[patent_app_country] => US
[patent_app_date] => 2018-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638390
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638390 | Process for manufacturing a cyclic urea adduct of an ethyleneamine compound | Aug 6, 2018 | Issued |
Array
(
[id] => 16261168
[patent_doc_number] => 10752585
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-25
[patent_title] => Process for the preparation of Zafirlukast and analogs thereof
[patent_app_type] => utility
[patent_app_number] => 16/646462
[patent_app_country] => US
[patent_app_date] => 2018-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4550
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 364
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646462
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/646462 | Process for the preparation of Zafirlukast and analogs thereof | Aug 5, 2018 | Issued |
Array
(
[id] => 18012105
[patent_doc_number] => 11504379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Amide compound, and Pin1 inhibitor, therapeutic agent for inflammatory diseases and therapeutic agent for cancer that use the same
[patent_app_type] => utility
[patent_app_number] => 16/636746
[patent_app_country] => US
[patent_app_date] => 2018-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18004
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16636746
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/636746 | Amide compound, and Pin1 inhibitor, therapeutic agent for inflammatory diseases and therapeutic agent for cancer that use the same | Aug 5, 2018 | Issued |